The evidence-based treatment of BD is described in guidelines, such as the Canadian Network for Mood and Anxiety Treatments (CANMAT) (Yatham et al., 2013) and the Dutch Guideline (Nolen et al., 2008). These guidelines state that, although pharmacotherapy forms the cornerstone of disorder management, the inclusion of psychosocial interventions and the incorporation of chronic disease management involving a healthcare team are also required. The explicit involvement of the patient and carers in the treatment and management processes with the aim of empowering the patient is also recommended (Nolen et al., 2008).